By now, the EUROFAN programme for the functional analysis of genes from the
yeast genome has attained its cruising speed. Indeed, several hundreds of
yeast mutants with no phenotype as tested by growth on standard media and n
o significant sequence similarity to proteins of known function are availab
le through the efforts of various laboratories. Based on the methodology in
itiated during the pilot project on yeast chromosome III (Yeast 13, 1547-15
62, 1997) we adapted it to High Throughput Screening (HTS), using robotics.
The first 100 different gene deletions from EUROSCARF, constructed in an F
Y1679 strain background, were run against a collection of about 300 inhibit
ors. Many of these inhibitors have not been reported until now to interfere
in vivo with growth of Saccharomyces cerevisiae. In the present paper we p
rovide a list of novel growth conditions and a compilation of 49 yeast dele
tants (from chromosomes II, IV, VII, X, XIV, XV) corresponding to 58% of th
e analysed genes, with at least one clear and stringent phenotype. The majo
rity of these deletants are sensitive to one or two compounds (monotropic p
henotype) while a distinct subclass of deletants displays a hyper-pleiotrop
ic phenotype with sensitivities to a dozen or more compounds. Therefore, ch
emotyping of unknown genes with a large spectrum of drugs opens new vistas
for a more in-depth functional analysis and a more precise definition of mo
lecular targets. Copyright (C) 1999 John Wiley & Sons, Ltd.